Peritoneal Dialysis Technique Survival: A Cohort Study

IF 9.4 1区 医学 Q1 UROLOGY & NEPHROLOGY
{"title":"Peritoneal Dialysis Technique Survival: A Cohort Study","authors":"","doi":"10.1053/j.ajkd.2024.03.012","DOIUrl":null,"url":null,"abstract":"<div><h3>Rationale &amp; Objective</h3><p>Reasons for transfer from peritoneal dialysis<span> (PD) to hemodialysis (HD) remain incompletely understood. Among incident and prevalent patients receiving PD, we evaluated the association of clinical factors, including prior treatment with HD, with PD technique survival.</span></p></div><div><h3>Study Design</h3><p>Retrospective cohort study.</p></div><div><h3>Setting &amp; Participants</h3><p>Adults who initiated PD at a Dialysis Clinic, Inc (DCI) outpatient facility between January 1, 2010, and September 30, 2019.</p></div><div><h3>Exposure</h3><p>The primary exposure of interest was timing of PD start, categorized as PD-first, PD-early, or PD-late. Other covariates included demographics, clinical characteristics, and routine laboratory results.</p></div><div><h3>Outcome</h3><p>Modality switch from PD to HD sustained for more than 90 days.</p></div><div><h3>Analytical Approach</h3><p>Multivariable Fine-Gray models with competing risks and time-varying covariates, stratified at 9 months to account for lack of proportionality.</p></div><div><h3>Results</h3><p>Among 5,224 patients who initiated PD at a DCI facility, 3,174 initiated dialysis with PD (“PD-first”), 942 transitioned from HD to PD within 90 days (“PD-early”), and 1,108 transitioned beyond 90 days (“PD-late”); 1,472 (28%) subsequently transferred from PD to HD. The PD-early and PD-late patients had a higher risk of transfer to HD as compared with PD-first patients (in the first 9 months: adjusted hazard ratio [AHR], 1.51 [95% CI, 1.17-1.96] and 2.41 [95% CI, 1.94-3.00], respectively; and after 9 months: AHR, 1.16 [95% CI, 0.99-1.35] and AHR, 1.43 [95% CI, 1.24-1.65], respectively). More peritonitis<span> episodes, fewer home visits, lower serum albumin levels, lower residual kidney function, and lower peritoneal clearance calculated with weekly Kt/V were additional risk factors for PD-to-HD transfer.</span></p></div><div><h3>Limitations</h3><p>Missing data on dialysis adequacy and residual kidney function, confounded by short PD technique survival.</p></div><div><h3>Conclusions</h3><p>Initiating dialysis with PD is associated with greater PD technique survival, though many of those who initiate PD-late in their dialysis course still experience substantial time on PD. Peritonitis, lower serum albumin, and lower Kt/V are risk factors for PD-to-HD transfer that may be amenable to intervention.</p></div><div><h3>Plain-Language Summary</h3><p>Peritoneal dialysis (PD) is an important kidney replacement modality with several potential advantages compared with in-center hemodialysis (HD). However, a substantial number of patients transfer to in-center HD early on, without having experienced the quality-of-life and other benefits that come with sustained maintenance of PD. Using retrospective data from a midsize national dialysis provider, we found that initiating dialysis with PD is associated with longer maintenance of PD, compared with initiating dialysis with HD and a later switch to PD. However, many of those who initiate PD-late in their dialysis course still experience substantial time on PD. Peritonitis, lower serum albumin, and lower small protein removal are other risk factors for PD-to-HD transfer that may be amenable to intervention.</p></div>","PeriodicalId":7419,"journal":{"name":"American Journal of Kidney Diseases","volume":null,"pages":null},"PeriodicalIF":9.4000,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Kidney Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0272638624007182","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale & Objective

Reasons for transfer from peritoneal dialysis (PD) to hemodialysis (HD) remain incompletely understood. Among incident and prevalent patients receiving PD, we evaluated the association of clinical factors, including prior treatment with HD, with PD technique survival.

Study Design

Retrospective cohort study.

Setting & Participants

Adults who initiated PD at a Dialysis Clinic, Inc (DCI) outpatient facility between January 1, 2010, and September 30, 2019.

Exposure

The primary exposure of interest was timing of PD start, categorized as PD-first, PD-early, or PD-late. Other covariates included demographics, clinical characteristics, and routine laboratory results.

Outcome

Modality switch from PD to HD sustained for more than 90 days.

Analytical Approach

Multivariable Fine-Gray models with competing risks and time-varying covariates, stratified at 9 months to account for lack of proportionality.

Results

Among 5,224 patients who initiated PD at a DCI facility, 3,174 initiated dialysis with PD (“PD-first”), 942 transitioned from HD to PD within 90 days (“PD-early”), and 1,108 transitioned beyond 90 days (“PD-late”); 1,472 (28%) subsequently transferred from PD to HD. The PD-early and PD-late patients had a higher risk of transfer to HD as compared with PD-first patients (in the first 9 months: adjusted hazard ratio [AHR], 1.51 [95% CI, 1.17-1.96] and 2.41 [95% CI, 1.94-3.00], respectively; and after 9 months: AHR, 1.16 [95% CI, 0.99-1.35] and AHR, 1.43 [95% CI, 1.24-1.65], respectively). More peritonitis episodes, fewer home visits, lower serum albumin levels, lower residual kidney function, and lower peritoneal clearance calculated with weekly Kt/V were additional risk factors for PD-to-HD transfer.

Limitations

Missing data on dialysis adequacy and residual kidney function, confounded by short PD technique survival.

Conclusions

Initiating dialysis with PD is associated with greater PD technique survival, though many of those who initiate PD-late in their dialysis course still experience substantial time on PD. Peritonitis, lower serum albumin, and lower Kt/V are risk factors for PD-to-HD transfer that may be amenable to intervention.

Plain-Language Summary

Peritoneal dialysis (PD) is an important kidney replacement modality with several potential advantages compared with in-center hemodialysis (HD). However, a substantial number of patients transfer to in-center HD early on, without having experienced the quality-of-life and other benefits that come with sustained maintenance of PD. Using retrospective data from a midsize national dialysis provider, we found that initiating dialysis with PD is associated with longer maintenance of PD, compared with initiating dialysis with HD and a later switch to PD. However, many of those who initiate PD-late in their dialysis course still experience substantial time on PD. Peritonitis, lower serum albumin, and lower small protein removal are other risk factors for PD-to-HD transfer that may be amenable to intervention.

Abstract Image

Abstract Image

腹膜透析技术的存活率:一项队列研究。
理由和目标:从腹膜透析(PD)转为血液透析(HD)的原因仍不完全清楚。在接受腹膜透析的偶发和常见患者中,我们评估了之前接受过血液透析治疗与腹膜透析技术存活率之间的关系:回顾性队列研究:2010年1月1日至2019年9月30日期间在透析诊所公司(DCI)门诊设施开始PD治疗的成人:关注的主要暴露是开始透析的时间,分为首次透析、早期透析或晚期透析。其他协变量包括人口统计学、临床特征和常规实验室结果:分析方法:分析方法:具有竞争风险和时变协变量的多变量Fine-Gray模型,在9个月时进行分层以考虑缺乏比例性:在 DCI 机构开始透析的 5224 名患者中,有 3174 人开始使用透析("先透析"),942 人在 90 天内从 HD 转为透析("早透析"),1108 人在 90 天后转为透析("晚透析");1472 人(28%)随后从透析转为 HD。与首次接受腹膜透析治疗的患者相比,腹膜透析早期患者和腹膜透析晚期患者转入 HD 的风险更高[头 9 个月的调整后危险比(aHR)分别为 1.51(95% CI:1.17-1.96)和 2.41(1.94-3.00),9 个月后的调整后危险比(aHR)分别为 1.16(0.99-1.35)和 1.43(1.24-1.65)]。腹膜炎发作次数较多、家访次数较少、血清白蛋白较低、残余肾功能较低以及用每周Kt/V计算的腹膜清除率较低是PD转HD的额外风险因素:局限性:透析充分性和残余肾功能数据缺失,且透析技术存活时间短:结论:使用腹膜透析开始透析与更高的腹膜透析技术存活率有关,尽管许多在透析过程中很晚才开始腹膜透析的患者仍需经历相当长的腹膜透析时间。腹膜炎、较低的血清白蛋白和较低的 Kt/V 是 PD 向 HD 转移的风险因素,可能需要进行干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Kidney Diseases
American Journal of Kidney Diseases 医学-泌尿学与肾脏学
CiteScore
20.40
自引率
2.30%
发文量
732
审稿时长
3-8 weeks
期刊介绍: The American Journal of Kidney Diseases (AJKD), the National Kidney Foundation's official journal, is globally recognized for its leadership in clinical nephrology content. Monthly, AJKD publishes original investigations on kidney diseases, hypertension, dialysis therapies, and kidney transplantation. Rigorous peer-review, statistical scrutiny, and a structured format characterize the publication process. Each issue includes case reports unveiling new diseases and potential therapeutic strategies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信